Can patients with intracerebral hemorrhage take Salvia miltiorrhiza (Danshen)?
Aug 24, 2022
Source: Cainiu Health
Dr. Yang Jun
Introduction
During the recovery phase of intracerebral hemorrhage, Salvia miltiorrhiza (Danshen) may be taken under the guidance of a local physician. Compound Danshen tablets primarily enhance coronary artery blood supply and have no significant therapeutic effect on hypertensive intracerebral hemorrhage. Oral administration is recommended, though efficacy is minimal. During the recovery phase of intracerebral hemorrhage, appropriate use of brain-tonifying medications with blood-activating and stasis-resolving properties may be considered; these are also suitable for sequelae following cerebral infarction.
Intracerebral hemorrhage (ICH) is a common condition among middle-aged and elderly individuals, hypertensive patients, and those with cerebral vascular malformations. Moreover, ICH carries a high mortality rate; thus, it is essential to possess a basic understanding of this disease. So, can patients with intracerebral hemorrhage take *Salvia miltiorrhiza* (Danshen)?
Can patients with intracerebral hemorrhage take Danshen?
During the recovery phase of intracerebral hemorrhage, patients may take Danshen under the guidance of their local physician. Compound Danshen tablets primarily enhance coronary artery blood supply and demonstrate no significant therapeutic effect on hypertensive intracerebral hemorrhage. Oral administration is possible but yields minimal clinical benefit. During recovery, patients may appropriately use neuroprotective medications with blood-activating and stasis-resolving properties. These agents may be used for sequelae of cerebral infarction, though their efficacy remains uncertain. Therefore, the primary management strategy for intracerebral hemorrhage involves functional rehabilitation exercises for the affected limbs. Secondly, prevention of recurrent cerebral infarction is critical. Causes of ICH are diverse; the most common include hypertension and atherosclerosis, followed by congenital cerebral vascular malformations or aneurysms and hematologic disorders.
Intracerebral hemorrhage is a common hemorrhagic cerebrovascular disease encountered clinically, with hypertension being the most frequent underlying cause. Consequently, controlling hypertension constitutes the cornerstone of ICH prevention. Commonly prescribed antihypertensive medications fall into several classes, including calcium channel blockers, ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), diuretics, and beta-blockers.
Patients are advised to maintain a light, low-sodium diet during recovery. If symptoms worsen, prompt medical evaluation at a hospital is strongly recommended. We hope this information proves helpful.
